Back to results

Active, not recruitingPhase 1Phase 2

VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease

NCT06874621

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

VYGR Site 840018

Los Angeles, California, United States

+22 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2025-03-03
Enrollment: 52 participants
Sponsor: Voyager Therapeutics
Purpose: treatment

Locations (23)

VYGR Site 840018Los Angeles, California, United States
VYGR Site 840016Orange, California, United States
VYGR Site 840022San Francisco, California, United States
VYGR Site 840008Stamford, Connecticut, United States
VYGR Site 840005Delray Beach, Florida, United States
VYGR Site 840021Fort Myers, Florida, United States
VYGR Site 840010Lady Lake, Florida, United States
VYGR Site 840015Miami, Florida, United States
VYGR Site 840014Miami, Florida, United States
VYGR Site 840024Miami, Florida, United States
VYGR Site 840006Orlando, Florida, United States
VYGR Site 840003Stuart, Florida, United States
VYGR Site 840004The Villages, Florida, United States
VYGR Site 840002Wellington, Florida, United States
VYGR Site 840020Winter Park, Florida, United States
VYGR Site 840007Decatur, Georgia, United States
VYGR Site 840012Toms River, New Jersey, United States
VYGR Site 840009Matthews, North Carolina, United States
VYGR Site 840011Plymouth Meeting, Pennsylvania, United States
VYGR Site 124002Ottawa, Ontario, Canada
VYGR Site 124001Toronto, Ontario, Canada
VYGR Site 124003Montreal, Quebec, Canada
VYGR Site 124004Montreal, Quebec, Canada

VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease — TrialFind